In this study, YH-306 inhibited FAK/PI3K/Rac1 pathway activation and the recruitment of Arp3 as well as the expression of MMP2 and MMP9, resulting in the suppression of CRC metastasis. This evidence concerns the gene RAC1 and colorectal carcinoma.